Retina Gallery ~ Full Sized Retina Images

Myopic CNVM - lacquer crack - recurrence 6 years later 31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 13431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 14031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 14131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 14131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 12731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 14131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 14031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
40 faili 1 lehel

31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.